Skip to main content
Erschienen in: World Journal of Surgery 11/2011

01.11.2011

Lithium-Associated Hyperparathyroidism: Surgical Strategies in the Era of Minimally Invasive Parathyroidectomy

verfasst von: Anita R. Skandarajah, F. Fausto Palazzo, Jean-François Henry

Erschienen in: World Journal of Surgery | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Lithium remains an effective treatment of bipolar affective disorder. The long-term use of lithium is associated with an alteration in parathyroid function that may culminate in hyperparathyroidism. The long-term effects of lithium use are variable due to its complex effects on calcium homeostasis and bone metabolism, and as a consequence the indications for surgery remain poorly defined. The optimal surgical strategy for lithium-associated hyperparathyroidism in the era of minimally invasive surgery is also the subject of debate. The aim of the present study was to evaluate the variable findings of lithium-associated parathyroid disease.

Methods

A retrospective review was performed of patients undergoing parathyroid surgery presenting with lithium-associated hyperparathyroidism from July 1999 until July 2009 at the university hospital La Timone, Marseille, and from October 2005 to July 2009 at Hammersmith Hospital, Imperial College, London. Fifteen patients underwent surgery for lithium-associated hyperparathyroidism. Clinical data including patient demographics, duration of lithium use, clinical manifestations of hyperparathyroidism, indications for surgery, and biochemical parameters preoperatively and postoperatively were reviewed. Preoperative imaging, the surgical procedure performed, operative findings, and histopathology were also analyzed.

Results

All 15 patients had preoperative imaging: sestamibi scanning showed that 10 patients had localized single-gland disease, 1 had multiple hot spots, and 4 had a negative scan. Ultrasonography demonstrated a single abnormal gland in 8 patients and multiple enlarged glands in 1 patient; the test was negative in 6. As a consequence of concordant preoperative imaging a minimally invasive approach (endoscopic or a focused lateral approach) was adopted in 3 patients. Focused surgery demonstrated an enlarged hyperplastic gland in 3 cases and resulted in normocalcemia in the immediate postoperative period. However, one patient has a serum calcium at the upper limit of normal and elevated parathyroid hormone (PTH) levels, suggestive of possible recurrence of disease at 15 months follow-up. One patient has permanent hypoparathyroidism. In those patients who had open procedures, final histology showed hyperplastic multiglandular disease in 10 patients (83.3%) of patients and single-gland disease in 2 patients (16.7%). None of these patients show evidence of recurrence at follow-up.

Conclusions

Lithium hyperparathyroidism is predominantly a multiglandular disease characterized by asymmetrical hyperplasia that is frequently associated with misleading or discordant localization studies. Bilateral neck exploration is therefore recommended in order to minimize the risk of disease recurrence.
Literatur
1.
Zurück zum Zitat Cade JF (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352PubMed Cade JF (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352PubMed
2.
Zurück zum Zitat Cade JF (1975) Lithium—when, why and how? Med J Aust 1:684–686PubMed Cade JF (1975) Lithium—when, why and how? Med J Aust 1:684–686PubMed
3.
Zurück zum Zitat Hundley JC, Woodrum DT, Saunders BD et al (2005) Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery 138:1027–1031 discussion 1031–1032PubMedCrossRef Hundley JC, Woodrum DT, Saunders BD et al (2005) Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery 138:1027–1031 discussion 1031–1032PubMedCrossRef
5.
Zurück zum Zitat Bendz H, Sjodin I, Toss G et al (1996) Hyperparathyroidism and long-term lithium therapy—a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240:357–365PubMedCrossRef Bendz H, Sjodin I, Toss G et al (1996) Hyperparathyroidism and long-term lithium therapy—a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240:357–365PubMedCrossRef
6.
Zurück zum Zitat Garfinkel PE, Ezrin C, Stancer HC (1973) Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2(7824):331–332PubMedCrossRef Garfinkel PE, Ezrin C, Stancer HC (1973) Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2(7824):331–332PubMedCrossRef
7.
Zurück zum Zitat Livingstone C, Rampes H (2006) Lithium: a review of its metabolic adverse effects. J Psychopharmacol 20:347–355PubMedCrossRef Livingstone C, Rampes H (2006) Lithium: a review of its metabolic adverse effects. J Psychopharmacol 20:347–355PubMedCrossRef
8.
Zurück zum Zitat Saxe A, Gibson G, Silveira E (1995) Effects of long-term lithium infusion on normal parathyroid tissue. Surgery 117:577–580PubMedCrossRef Saxe A, Gibson G, Silveira E (1995) Effects of long-term lithium infusion on normal parathyroid tissue. Surgery 117:577–580PubMedCrossRef
9.
Zurück zum Zitat Saxe AW, Gibson G (1991) Lithium increases tritiated thymidine uptake by abnormal human parathyroid tissue. Surgery 110:1067–1076 discussion 1076–1077PubMed Saxe AW, Gibson G (1991) Lithium increases tritiated thymidine uptake by abnormal human parathyroid tissue. Surgery 110:1067–1076 discussion 1076–1077PubMed
11.
Zurück zum Zitat Awad SS, Miskulin J, Thompson N (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27:486–488. doi:10.1007/s00268-002-6824-4 PubMedCrossRef Awad SS, Miskulin J, Thompson N (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27:486–488. doi:10.​1007/​s00268-002-6824-4 PubMedCrossRef
12.
Zurück zum Zitat Dwight T, Kytola S, Teh BT et al (2002) Genetic analysis of lithium-associated parathyroid tumors. Eur J Endocrinol 146:619–627PubMedCrossRef Dwight T, Kytola S, Teh BT et al (2002) Genetic analysis of lithium-associated parathyroid tumors. Eur J Endocrinol 146:619–627PubMedCrossRef
13.
Zurück zum Zitat Zamani A, Omrani GR, Nasab MM (2009) Lithium’s effect on bone mineral density. Bone 44:331–334PubMedCrossRef Zamani A, Omrani GR, Nasab MM (2009) Lithium’s effect on bone mineral density. Bone 44:331–334PubMedCrossRef
14.
Zurück zum Zitat Baran DT, Schwartz MP, Bergfeld MA et al (1978) Lithium inhibition of bone mineralization and osteoid formation. J Clin Invest 61:1691–1696PubMedCrossRef Baran DT, Schwartz MP, Bergfeld MA et al (1978) Lithium inhibition of bone mineralization and osteoid formation. J Clin Invest 61:1691–1696PubMedCrossRef
15.
Zurück zum Zitat Misra M, Papakostas GI, Klibanski A (2004) Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 65:1607–1618 quiz 590, 760–761PubMedCrossRef Misra M, Papakostas GI, Klibanski A (2004) Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 65:1607–1618 quiz 590, 760–761PubMedCrossRef
16.
Zurück zum Zitat Mak TW, Shek CC, Chow CC et al (1998) Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab 83:3857–3859PubMedCrossRef Mak TW, Shek CC, Chow CC et al (1998) Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab 83:3857–3859PubMedCrossRef
17.
Zurück zum Zitat Sloand JA, Shelly MA (2006) Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48:832–847PubMedCrossRef Sloand JA, Shelly MA (2006) Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48:832–847PubMedCrossRef
18.
19.
Zurück zum Zitat National Institutes of Health (1991) Consensus development conference statement. J Bone Miner Res Suppl 2:S9–S13 National Institutes of Health (1991) Consensus development conference statement. J Bone Miner Res Suppl 2:S9–S13
20.
Zurück zum Zitat Diagnosis, management of asymptomatic primary hyperparathyroidism (1990) National Institutes of Health Consensus Development Conference, October 29–31, 1990. Nat Inst Health 8:1–18 Diagnosis, management of asymptomatic primary hyperparathyroidism (1990) National Institutes of Health Consensus Development Conference, October 29–31, 1990. Nat Inst Health 8:1–18
21.
Zurück zum Zitat Gregoor PS, de Jong GM (2007) Lithium hypercalcemia, hyperparathyroidism, and cinacalcet. Kidney Int 71:470PubMedCrossRef Gregoor PS, de Jong GM (2007) Lithium hypercalcemia, hyperparathyroidism, and cinacalcet. Kidney Int 71:470PubMedCrossRef
22.
Zurück zum Zitat Szalat A, Mazeh H, Freund HR (2009) Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 160:317–323PubMedCrossRef Szalat A, Mazeh H, Freund HR (2009) Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 160:317–323PubMedCrossRef
23.
Zurück zum Zitat Dalan R, Leow MK, Jong M (2007) Multiple endocrinopathies associated with lithium therapy. Endocr Pract 13:758–763PubMed Dalan R, Leow MK, Jong M (2007) Multiple endocrinopathies associated with lithium therapy. Endocr Pract 13:758–763PubMed
24.
Zurück zum Zitat Khandwala HM, Van Uum S (2006) Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract 12:54–58PubMed Khandwala HM, Van Uum S (2006) Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract 12:54–58PubMed
25.
Zurück zum Zitat Lions C, Precloux P, Burckard E et al (2005) Important hypercalcaemia due to hyperparathyroidism induced by lithium. Ann Fr Anesth Reanim 24:270–273 (in French)PubMed Lions C, Precloux P, Burckard E et al (2005) Important hypercalcaemia due to hyperparathyroidism induced by lithium. Ann Fr Anesth Reanim 24:270–273 (in French)PubMed
26.
Zurück zum Zitat Pieri-Balandraud N, Hugueny P, Henry JF et al (2001) Hyperparathyroidism induced by lithium. A new case. Rev Med Interne 22:460–464 (in French)PubMedCrossRef Pieri-Balandraud N, Hugueny P, Henry JF et al (2001) Hyperparathyroidism induced by lithium. A new case. Rev Med Interne 22:460–464 (in French)PubMedCrossRef
27.
Zurück zum Zitat Laroche M, Lamboley V, Amigues JM et al (1997) Hyperparathyroidism during lithium therapy. Two new cases. Rev Rhum Engl Ed 64:132–134PubMed Laroche M, Lamboley V, Amigues JM et al (1997) Hyperparathyroidism during lithium therapy. Two new cases. Rev Rhum Engl Ed 64:132–134PubMed
28.
Zurück zum Zitat de Celis G, Fiter M, Latore X et al (2008) Oxyphilic parathyroid adenoma and lithium therapy. Lancet 352:1070CrossRef de Celis G, Fiter M, Latore X et al (2008) Oxyphilic parathyroid adenoma and lithium therapy. Lancet 352:1070CrossRef
29.
Zurück zum Zitat McHenry CR, Rosen IB, Rotstein LE et al (1990) Lithiumogenic disorders of the thyroid and parathyroid glands as surgical disease. Surgery 108:1001–1005PubMed McHenry CR, Rosen IB, Rotstein LE et al (1990) Lithiumogenic disorders of the thyroid and parathyroid glands as surgical disease. Surgery 108:1001–1005PubMed
30.
Zurück zum Zitat Abdullah H, Bliss R, Guinea AI et al (1999) Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 86:91–93PubMedCrossRef Abdullah H, Bliss R, Guinea AI et al (1999) Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 86:91–93PubMedCrossRef
31.
Zurück zum Zitat Nordenstrom J, Strigard K, Perbeck L et al (1992) Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 158:207–211PubMed Nordenstrom J, Strigard K, Perbeck L et al (1992) Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 158:207–211PubMed
32.
Zurück zum Zitat Jarhult J, Ander S, Asking B et al (2010) Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg 97:1680–1685PubMedCrossRef Jarhult J, Ander S, Asking B et al (2010) Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg 97:1680–1685PubMedCrossRef
33.
Zurück zum Zitat Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159PubMedCrossRef Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159PubMedCrossRef
34.
Zurück zum Zitat Sebag F, Hubbard JG, Maweja S et al (2003) Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 134:1038–1041 discussion 1041–1042PubMedCrossRef Sebag F, Hubbard JG, Maweja S et al (2003) Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 134:1038–1041 discussion 1041–1042PubMedCrossRef
Metadaten
Titel
Lithium-Associated Hyperparathyroidism: Surgical Strategies in the Era of Minimally Invasive Parathyroidectomy
verfasst von
Anita R. Skandarajah
F. Fausto Palazzo
Jean-François Henry
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1220-6

Weitere Artikel der Ausgabe 11/2011

World Journal of Surgery 11/2011 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.